CLGN - CollPlant Biotechnologies GAAP EPS of -$0.13 misses by $0.09, revenue of $2.06M misses by $0.6M
2025-05-28 07:01:23 ET
More on CollPlant Biotechnologies
- CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript
- Collplant plans clinical trials for dermal filler and advances regenerative implants
- Seeking Alpha’s Quant Rating on CollPlant Biotechnologies
- Historical earnings data for CollPlant Biotechnologies
- Financial information for CollPlant Biotechnologies